 |
PDBsum entry 4q2k
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
4q2k
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Macrocyclic protease inhibitors with reduced peptide character.
|
 |
|
Authors
|
 |
K.C.Chua,
M.Pietsch,
X.Zhang,
S.Hautmann,
H.Y.Chan,
J.B.Bruning,
M.Gütschow,
A.D.Abell.
|
 |
|
Ref.
|
 |
Angew Chem Int Ed Engl, 2014,
53,
7828-7831.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
There is a real need for simple structures that define a β-strand conformation,
a secondary structure that is central to peptide-protein interactions. For
example, protease substrates and inhibitors almost universally adopt this
geometry on active site binding. A planar pyrrole is used to replace two amino
acids of a peptide backbone to generate a simple macrocycle that retains the
required geometry for active site binding. The resulting β-strand templates
have reduced peptide character and provide potent protease inhibitors with the
attachment of an appropriate amino aldehyde to the C-terminus. Picomolar
inhibitors of cathepsin L and S are reported and the mode of binding of one
example to the model protease chymotrypsin is defined by X-ray crystallography.
|
 |
|
|
|
|
 |